Skip to main content

Jacques Planas Morin

Institutions of which they are part

Biomedical Research in Urology
Vall Hebron Institut de Recerca

Jacques Planas Morin

Institutions of which they are part

Biomedical Research in Urology
Vall Hebron Institut de Recerca

Research lines

Hormone therapy and castrate resistant prostate cancer (Clinical research)

One main objective is the optimization of androgen suppression and to know its safety profile, specifically in the areas of bone mass loss, the metabolic disturbances and cognitive performance. How to perform early diagnosis of CRPC, and how to follow up the new treatments are also objectives of this line.

IP: Jacques Planas Morin

Projects

Incorporación de métodos de imagen y perfiles moleculares para mejorar el cribado de cáncer de próstata en portadores de mutaciones en genes de las vías de reparación de ADN.

IP: Olga Méndez Fernández
Collaborators: Berta Miró Cau, Marc Simo Perdigo, David Ruiz Casajuana, Jacques Planas Morin, Richard Mast
Funding agency: Instituto de Salud Carlos III
Funding: 127500
Reference: PI23/01310
Duration: 01/01/2024 - 31/12/2026

Rercerca biomèdica en urologia

IP: Joan Morote Robles
Collaborators: Fernando Lozano Palacio, Inés de Torres Ramirez, Rercerca biomèdica en urologia , Enric Trilla Herrera, Olga Méndez Fernández, Ana Celma Domènech, Mercè Cuadras Solé, Carlos Serrano Burgos, Albert Carrión Puig , Enric Miret Alomar, Maria Eugenia Semidey Raven, Carles Xavier Raventós Busquets, David Ruiz Casajuana, Jacques Planas Morin, Richard Mast, Anna Santamaria Margalef
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 00858
Duration: 01/01/2022 - 30/06/2025

Nuevas estrategias para la mejora del diagnóstico y el manejo terapéutico de los portadores de mutaciones en BRCA2

IP: Anna Santamaria Margalef
Collaborators: Mercè Cuadras Solé, Jacques Planas Morin
Funding agency: Instituto de Salud Carlos III
Funding: 159720
Reference: PI21/00977
Duration: 01/01/2022 - 31/12/2024

Radiogenomics for the prediction of prostate cancer aggressiveness through artificial intelligence.

IP: Joan Morote Robles
Collaborators: Inés de Torres Ramirez, Ana Celma Domènech, Jacques Planas Morin, Richard Mast, Lucas Regis Plácido
Funding agency: Instituto de Salud Carlos III
Funding: 159720
Reference: PI20/01666
Duration: 01/01/2021 - 30/06/2025

Related news

The work led by Dr. Regis demonstrates that performing robotic reconstruction after radical prostatectomy is associated with better urinary control.

A clinical trial with the prototype of the device shows that the use of this technology improves patient monitoring by nurses and reduces post-surgical complications.

One more year, we join the Movember movement to raise awareness of the need for research to improve men's health and, in particular, that of patients with prostate cancer.

Related professionals

Alba Estela García Fernández

Alba Estela García Fernández

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Veronica Estepa Calvo

Veronica Estepa Calvo

Research technician
Reconstructive Surgery of the Locomotor System
Read more
Zuleika del Carmen Gonzalez Ramos

Zuleika del Carmen Gonzalez Ramos

Predoctoral researcher
Multidisciplinary Nursing Research Group
Read more
Paula Fernández Álvarez

Paula Fernández Álvarez

Research technician
Genetics Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.